Intellectual Property India Publishes Patent Application for 'Improved Process For Synthesis Of Nicotinamide Riboside Chloride' Filed by Blue Helix Health AS

MUMBAI, India, Aug. 29 -- Intellectual Property India has published a patent application (202421012750 A) filed by Blue Helix Health AS, Snaroya, Norway, on Feb. 22, 2024, for 'improved process for synthesis of nicotinamide riboside chloride.'

Inventor(s) include Bohan Frode; Malkannagari, Ramani; and Gundapuneni, Raghava Rao.

The application for the patent was published on Aug. 29, under issue no. 35/2025.

According to the abstract released by the Intellectual Property India: "The present invention discloses an improved process for synthesis of nicotinamide riboside chloride (NRCl)."

Disclaimer: Curated by HT Syndication.